Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 35: 431-434, 1989;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Monk, J.
Right arrow Articles by Wreghitt, T. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Monk, J.
Right arrow Articles by Wreghitt, T. G.

Clinical Chemistry, Vol 35, 431-434, Copyright © 1989 by American Association for Clinical Chemistry

Oligoclonal banding in serum from heart-transplant recipients

J Monk, J Calvin, CP Price and TG Wreghitt
Department of Clinical Biochemistry, Addenbrooke's Hospital, Cambridge, U.K.

Sera from heart-transplant patients on immunosuppressive drugs frequently exhibit pronounced oligoclonal banding patterns. There is a strong association between the appearance of these immunoglobulins and infection with cytomegalovirus (CMV) in these patients. Fainter bands were seen both in patients with CMV infection and with various other infections. We saw no oligoclonal banding in electrophoretograms of sera of heart-transplant patients free of known infection.




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by the American Association for Clinical Chemistry.